Clinical Trial Update: Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing rituximab plus sargramostim versus rituximab alone in relapsed follicular B-cell lymphoma (a form of non-Hodgkin lymphoma) was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• sargramostim (sargramostim)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Lymphoma, Follicular | Phase 2 | Status: TERMINATED | Results posted: 2010-08-30